Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)

ClinicalTrials.gov ID: NCT06467344

Public ClinicalTrials.gov record NCT06467344. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 21, 2026, 2:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

ACDN-01-001: Open-Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Subretinal ACDN-01 in Participants With ABCA4-related Retinopathy

Study identification

NCT ID: NCT06467344
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1, Phase 2
Lead sponsor: Ascidian Therapeutics, Inc; Industry
Enrollment: 15 participants

Conditions and interventions

Conditions

Interventions

ACDN-01 Drug

Drug

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 10, 2024
Primary completion: Jul 31, 2030
Completion: Nov 30, 2030
Last update posted: Dec 1, 2025

2024 – 2030

United States locations

U.S. sites: 10
U.S. states: 8
U.S. cities: 10

Facility	City	State	ZIP	Site status
University of San Francisco	San Francisco	California	94158	Recruiting
Vitreo Retinal Associates	Gainesville	Florida	32607	Recruiting
Bascom Palmer Eye Institute	Miami	Florida	33136	Recruiting
Wilmer Eye Institute at John Hopkins	Baltimore	Maryland	21218	Recruiting
Massachusetts Eye and Ear	Boston	Massachusetts	02114	Recruiting
University of Michigan Kellogg Eye Center	Ann Arbor	Michigan	48105	Recruiting
Cincinnati Eye Institute	Cincinnati	Ohio	45245	Recruiting
Casey Eye Institute OHSU	Portland	Oregon	97239	Recruiting
Retina Foundation of the Southwest	Dallas	Texas	75382	Recruiting
Retina Consultants of Texas	Houston	Texas	77401	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06467344, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Dec 1, 2025 · Synced May 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06467344 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →